NASDAQ: AUPHAurinia Pharmaceuticals Inc Stock Ownership - Who owns Aurinia Pharmaceuticals?
Insider buying vs selling
Have Aurinia Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Stephen P. Robertson | EVP General Counsel | 2024-03-06 | 57,745 | $5.60 | $323.37kSell |
| Peter Greenleaf | Chief Executive Officer | 2024-03-06 | 126,981 | $5.60 | $711.09kSell |
| Matthew Maxwell Donley | EVP Ops Strategy | 2024-03-06 | 40,665 | $5.51 | $224.06kSell |
| Joseph M. Miller | Chief Financial Officer | 2024-03-06 | 34,811 | $5.60 | $194.94kSell |
| Scott Michael Habig | Chief Commercial Officer | 2024-03-06 | 17,777 | $5.60 | $99.55kSell |
| Volker Knappertz | EVP Research and Development | 2024-02-27 | 4,930 | $6.10 | $30.07kSell |
| Scott Michael Habig | Chief Commercial Officer | 2024-02-20 | 15,867 | $5.48 | $86.95kSell |
| Volker Knappertz | EVP Research and Development | 2024-02-20 | 25,146 | $5.48 | $137.80kSell |
| David Rw Jayne | Director | 2023-05-23 | 8,733 | $11.26 | $98.33kSell |
| Daniel Billen | Director | 2023-05-23 | 4,650 | $11.26 | $52.36kSell |
AUPH insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when AUPH insiders and whales buy or sell their stock.
AUPH Shareholders
What type of owners hold Aurinia Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Armistice Capital LLC | 6.59% | 9,536,000 | $47.97M | Institution |
| Blackrock Inc | 6.17% | 8,921,049 | $44.87M | Institution |
| Nea Management Company LLC | 2.75% | 3,969,834 | $19.97M | Institution |
| State Street Corp | 1.87% | 2,704,382 | $13.60M | Institution |
| Nuveen Asset Management LLC | 1.63% | 2,352,125 | $11.83M | Institution |
| Goldman Sachs Group Inc | 1.42% | 2,048,456 | $10.30M | Institution |
| Geode Capital Management LLC | 1.09% | 1,569,136 | $7.89M | Institution |
| Peter Greenleaf | 1.05% | 1,522,114 | $7.66M | Insider |
| Vanguard Group Inc | 1.04% | 1,510,498 | $7.60M | Institution |
| Morgan Stanley | 1.01% | 1,454,826 | $7.32M | Institution |
AUPH vs Biotech Stocks
Aurinia Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.